{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:31:45Z","timestamp":1775061105319,"version":"3.50.1"},"reference-count":123,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,1]],"date-time":"2027-04-01T00:00:00Z","timestamp":1806537600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["AI123321"],"award-info":[{"award-number":["AI123321"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007602","name":"University of California, Riverside","doi-asserted-by":"publisher","award":["NIFA-NIFAHatch-225935"],"award-info":[{"award-number":["NIFA-NIFAHatch-225935"]}],"id":[{"id":"10.13039\/100007602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI152220"],"award-info":[{"award-number":["AI152220"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI136118"],"award-info":[{"award-number":["AI136118"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI-138139"],"award-info":[{"award-number":["R01 AI-138139"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI153100"],"award-info":[{"award-number":["AI153100"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016230","name":"Steven and Alexandra Cohen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014731","name":"Global Lyme Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.pt.2026.02.004","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:30:17Z","timestamp":1773693017000},"page":"222-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Polypharmacology in malaria treatment: single drugs, multiple mechanisms, greater impact"],"prefix":"10.1016","volume":"42","author":[{"given":"Mira","family":"Mili\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prisca","family":"Obi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7218-4521","authenticated-orcid":false,"given":"Christopher D.","family":"Vanderwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-1400","authenticated-orcid":false,"given":"Choukri","family":"Ben Mamoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4862-9292","authenticated-orcid":false,"given":"Karine G.","family":"Le Roch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2026.02.004_bb0005","series-title":"World malaria report","first-page":"2025","author":"WHO","year":"2025"},{"key":"10.1016\/j.pt.2026.02.004_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000412","article-title":"Some lessons for the future from the Global Malaria Eradication Programme (1955\u20131969)","volume":"8","author":"Najera","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.pt.2026.02.004_bb0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12936-025-05398-3","article-title":"Rethinking malaria elimination: a perspective on challenges and solutions in Angola","volume":"24","author":"Domingos","year":"2025","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.02.004_bb0020","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","article-title":"Malaria","volume":"391","author":"Ashley","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2026.02.004_bb0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CMR.00079-12","article-title":"Human infections and detection of Plasmodium knowlesi","volume":"26","author":"Singh","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.pt.2026.02.004_bb0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1475-2875-13-68","article-title":"First case of a naturally acquired human infection with Plasmodium cynomolgi","volume":"13","author":"Ta","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.02.004_bb0035","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3201\/eid2510.190448","article-title":"Plasmodium cynomolgi as cause of malaria in tourist to Southeast Asia, 2018","volume":"25","author":"Hartmeyer","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.004_bb0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/cc2183","article-title":"Clinical review: severe malaria","volume":"7","author":"Trampuz","year":"2003","journal-title":"Crit. Care"},{"key":"10.1016\/j.pt.2026.02.004_bb0045","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1126\/science.8009217","article-title":"Malaria pathogenesis","volume":"264","author":"Miller","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.pt.2026.02.004_bb0050","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","article-title":"Malaria: biology and disease","volume":"167","author":"Cowman","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.pt.2026.02.004_bb0055","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12936-022-04301-8","article-title":"Severe malaria","volume":"21","author":"White","year":"2022","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.02.004_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13690-025-01772-4","article-title":"Prevalence, predictors and adverse perinatal outcomes of placental malaria in sub-Saharan Africa: a systematic review and meta-analysis","volume":"83","author":"Alemayehu","year":"2025","journal-title":"Arch. Public Health"},{"key":"10.1016\/j.pt.2026.02.004_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003890","article-title":"Clinical impact of vivax malaria: a collection review","volume":"19","author":"Phyo","year":"2022","journal-title":"PLoS Med."},{"key":"10.1016\/j.pt.2026.02.004_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.696598","article-title":"Basic research of Plasmodium vivax biology enabling its management as a clinical and public health problem","volume":"11","author":"Baird","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.pt.2026.02.004_bb0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.pt.2024.04.015","article-title":"The biology and pathogenesis of vivax malaria","volume":"40","author":"Anstey","year":"2024","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2026.02.004_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0004549","article-title":"Performance characteristics and potential public health impact of improved pre-erythrocytic malaria vaccines targeting childhood burden","volume":"5","author":"Malinga","year":"2025","journal-title":"PLoS Glob. Public Health"},{"key":"10.1016\/j.pt.2026.02.004_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-025-01078-0","article-title":"The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S\/AS01E","volume":"10","author":"Ali","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.pt.2026.02.004_bb0090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.pt.2021.04.006","article-title":"Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials","volume":"37","author":"Duffey","year":"2021","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2026.02.004_bb0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41579-024-01099-x","article-title":"Towards next-generation treatment options to combat Plasmodium falciparum malaria","volume":"23","author":"Okombo","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.pt.2026.02.004_bb0100","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","article-title":"The emergence of artemisinin partial resistance in Africa: how do we respond?","volume":"24","author":"Rosenthal","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.004_bb0105","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/S1473-3099(25)00013-1","article-title":"Impact of the Global Fund Regional Artemisinin-resistance Initiative on malaria control and elimination in the Greater Mekong subregion of Southeast Asia","volume":"25","author":"Pley","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.004_bb0110","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0140-6736(15)00417-1","article-title":"Averting a malaria disaster: will insecticide resistance derail malaria control?","volume":"387","author":"Hemingway","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2026.02.004_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/s13071-025-07049-7","article-title":"Building resilience against the growing threat of arboviruses: a scoping review of Aedes vector surveillance, control strategies and insecticide resistance in Africa","volume":"18","author":"Oxborough","year":"2025","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.pt.2026.02.004_bb0120","first-page":"141","article-title":"Climate change and mosquito-borne disease","volume":"109","author":"Reiter","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.pt.2026.02.004_bb0125","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.3390\/microorganisms13092034","article-title":"Vectors on the move: how climate change fuels the spread of Arboviruses in Europe","volume":"13","author":"Carbone","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.pt.2026.02.004_bb0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1473-3099(20)30700-3","article-title":"Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis","volume":"21","author":"Weiss","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.004_bb0135","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025486","article-title":"Malaria parasite liver infection and exoerythrocytic biology","volume":"7","author":"Vaughan","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.pt.2026.02.004_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2022.102193","article-title":"Plasmodium falciparum resistance to artemisinin-based combination therapies","volume":"69","author":"Ward","year":"2022","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.pt.2026.02.004_bb0145","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3390\/biomedicines13061270","article-title":"Malaria vaccines and global equity: a scoping review of current progress and future directions","volume":"13","author":"Kaithamanakallam","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.pt.2026.02.004_bb0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(23)00431-0","article-title":"Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis","volume":"24","author":"Rajasekhar","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.004_bb0155","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm.3073","article-title":"Malaria biology and disease pathogenesis: insights for new treatments","volume":"19","author":"Miller","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2026.02.004_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpddr.2025.100602","article-title":"Antimalarial drug resistance and drug discovery: learning from the past to innovate the future","volume":"28","author":"Theodoridis","year":"2025","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.pt.2026.02.004_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria vaccines: recent advances and new horizons","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pt.2026.02.004_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.100168","article-title":"Compound management in a virtual research organization: the cornerstone of a reliable MMV discovery engine","volume":"29","author":"Adam","year":"2024","journal-title":"SLAS Discov."},{"key":"10.1016\/j.pt.2026.02.004_bb0175","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41573-024-00933-4","article-title":"Combating antimicrobial resistance in malaria, HIV and tuberculosis","volume":"23","author":"Duffey","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pt.2026.02.004_bb0180","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cmi.2025.03.009","article-title":"The non-artemisinin antimalarial drugs under development: a review","volume":"31","author":"Okwu","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.pt.2026.02.004_bb0185","article-title":"Imidazolopiperazines as next-generation antimalarial agents: a scoping review of efficacy, mechanisms of action and resistance; prospects for future development","volume":"12","author":"Maiga","year":"2025","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.004_bb0190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jcph.6138","article-title":"Pharmacokinetics of ganaplacide and lumefantrine in adults, adolescents, and children with Plasmodium falciparum malaria treated with ganaplacide plus lumefantrine solid dispersion formulation: analysis of data from a multinational phase 2 study","volume":"65","author":"Sangana","year":"2025","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.pt.2026.02.004_bb0195","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1021\/ml4004414","article-title":"Antimalarial drug discovery: from quinine to the dream of eradication","volume":"4","author":"Renslo","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.pt.2026.02.004_bb0200","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1113\/JP275236","article-title":"Ivermectin and its target molecules: shared and unique modulation mechanisms of ion channels and receptors by ivermectin","volume":"596","author":"Chen","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.pt.2026.02.004_bb0205","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1574-6976.2006.00024.x","article-title":"Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes","volume":"30","author":"Macheboeuf","year":"2006","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.pt.2026.02.004_bb0210","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.1117280109","article-title":"Amphotericin primarily kills yeast by simply binding ergosterol","volume":"109","author":"Gray","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.02.004_bb0215","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1021\/acs.jctc.7b00337","article-title":"Multi-phase solvation model for biological membranes: molecular action mechanism of amphotericin B","volume":"13","author":"Falcon-Gonzalez","year":"2017","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.pt.2026.02.004_bb0220","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1128\/AAC.03570-14","article-title":"The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug","volume":"58","author":"Mesa-Arango","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2026.02.004_bb0225","doi-asserted-by":"crossref","first-page":"13991","DOI":"10.1073\/pnas.94.25.13991","article-title":"DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance","volume":"94","author":"Zhao","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.02.004_bb0230","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1358\/dot.2002.38.9.696536","article-title":"Imatinib mesylate (Gleevec, Glivec): a new therapy for chronic myeloid leukemia and other malignancies","volume":"38","author":"Hernandez-Boluda","year":"2002","journal-title":"Drugs Today"},{"key":"10.1016\/j.pt.2026.02.004_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-54490-3_1","article-title":"Imatinib mesylate","volume":"201","author":"Waller","year":"2014","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.pt.2026.02.004_bb0240","article-title":"Imatinib: a breakthrough of targeted therapy in cancer","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Chemother. Res. Pract."},{"key":"10.1016\/j.pt.2026.02.004_bb0245","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/11318860-000000000-00000","article-title":"Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies","volume":"23","author":"Papaetis","year":"2009","journal-title":"BioDrugs"},{"key":"10.1016\/j.pt.2026.02.004_bb0250","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.pt.2026.02.004_bb0255","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12012-007-0015-3","article-title":"Role of anthracyclines in the era of targeted therapy","volume":"7","author":"Cortes-Funes","year":"2007","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.pt.2026.02.004_bb0260","first-page":"670","article-title":"The anthracyclines: will we ever find a better doxorubicin?","volume":"19","author":"Weiss","year":"1992","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.pt.2026.02.004_bb0265","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","article-title":"Doxorubicin pathways: pharmacodynamics and adverse effects","volume":"21","author":"Thorn","year":"2011","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.pt.2026.02.004_bb0270","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1093\/nar\/gkn302","article-title":"Mechanistic studies on bleomycin-mediated DNA damage: multiple binding modes can result in double-stranded DNA cleavage","volume":"36","author":"Chen","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pt.2026.02.004_bb0275","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1021\/cr960438a","article-title":"Cleavage of nucleic acids by bleomycin","volume":"98","author":"Burger","year":"1998","journal-title":"Chem. Rev."},{"key":"10.1016\/j.pt.2026.02.004_bb0280","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-10-144","article-title":"Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria","volume":"10","author":"Achan","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.02.004_bb0285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eng.2018.11.011","article-title":"Artemisinin, the magic drug discovered from traditional Chinese medicine","volume":"5","author":"Wang","year":"2019","journal-title":"Engineering"},{"key":"10.1016\/j.pt.2026.02.004_bb0290","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.1073\/pnas.93.21.11865","article-title":"On the molecular mechanism of chloroquine\u2019s antimalarial action","volume":"93","author":"Sullivan","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.02.004_bb0295","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1021\/cr078274t","article-title":"Interplay between malaria, crystalline hemozoin formation, and antimalarial drug action and design","volume":"108","author":"Weissbuch","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.pt.2026.02.004_bb0300","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.1700125114","article-title":"Antimalarials inhibit hematin crystallization by unique drug-surface site interactions","volume":"114","author":"Olafson","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.02.004_bb0305","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jinorgbio.2005.11.005","article-title":"Interactions of quinoline antimalarials with hematin in solution","volume":"100","author":"Egan","year":"2006","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.pt.2026.02.004_bb0310","doi-asserted-by":"crossref","first-page":"22946","DOI":"10.1073\/pnas.1910123116","article-title":"Mode of action of quinoline antimalarial drugs in red blood cells infected by Plasmodium falciparum revealed in vivo","volume":"116","author":"Kapishnikov","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.02.004_bb0315","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau3174","article-title":"Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay","volume":"11","author":"Dziekan","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2026.02.004_bb0320","doi-asserted-by":"crossref","first-page":"10111","DOI":"10.1038\/ncomms10111","article-title":"Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2026.02.004_bb0325","doi-asserted-by":"crossref","first-page":"12099","DOI":"10.3390\/cimb46110718","article-title":"The antiviral and antimalarial prodrug artemisinin from the Artemisia species: a review","volume":"46","author":"Das","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.pt.2026.02.004_bb0330","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/molecules15031705","article-title":"The molecular mechanism of action of artemisinin\u2014the debate continues","volume":"15","author":"O\u2019Neill","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.pt.2026.02.004_bb0335","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.1104063108","article-title":"Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion","volume":"108","author":"Klonis","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.02.004_bb0340","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jac\/dkt486","article-title":"Rapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential","volume":"69","author":"Antoine","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.pt.2026.02.004_bb0345","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/jo991585m","article-title":"Biomimetic Fe(II)-mediated degradation of arteflene (Ro-42-1611). The first EPR spin-trapping evidence for the previously postulated secondary carbon-centered cyclohexyl radical","volume":"65","author":"O\u2019Neill","year":"2000","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.pt.2026.02.004_bb0350","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1021\/ja973080o","article-title":"Unified mechanistic framework for the Fe(II)-induced cleavage of qinghaosu and derivatives\/analogues. The first spin-trapping evidence for the previously postulated secondary C-4 radical","volume":"120","author":"Wu","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pt.2026.02.004_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113193","article-title":"Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research","volume":"213","author":"Patel","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pt.2026.02.004_bb0360","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pt.2022.12.006","article-title":"Lipid peroxidation and its repair in malaria parasites","volume":"39","author":"Wagner","year":"2023","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2026.02.004_bb0365","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1073\/pnas.1600459113","article-title":"Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7","volume":"113","author":"Ismail","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.02.004_bb0370","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","article-title":"Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome","volume":"9","author":"Bridgford","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2026.02.004_bb0375","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/AAC.03663-14","article-title":"Antimalarial action of artesunate involves DNA damage mediated by reactive oxygen species","volume":"59","author":"Gopalakrishnan","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2026.02.004_bb0380","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fcimb.2018.00256","article-title":"Artemisinin derivatives and synthetic trioxane trigger apoptotic cell death in asexual stages of plasmodium","volume":"8","author":"Gunjan","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.pt.2026.02.004_bb0385","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/1521-3773(20010518)40:10<1954::AID-ANIE1954>3.0.CO;2-9","volume":"40","author":"Robert","year":"2001","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.pt.2026.02.004_bb0390","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1128\/AAC.01033-07","article-title":"Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials","volume":"52","author":"Creek","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2026.02.004_bb0395","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chemphyslip.2009.04.005","article-title":"Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid","volume":"160","author":"Kumura","year":"2009","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.pt.2026.02.004_bb0400","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/cmdc.200700108","article-title":"The Fe2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediates","volume":"2","author":"Haynes","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pt.2026.02.004_bb0405","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016115","article-title":"A second mechanism employed by artemisinins to suppress Plasmodium falciparum hinges on inhibition of hematin crystallization","volume":"296","author":"Ma","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2026.02.004_bb0410","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pt.2009.12.005","article-title":"Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination","volume":"26","author":"Wells","year":"2010","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2026.02.004_bb0415","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijpddr.2020.12.004","article-title":"Primaquine for Plasmodium vivax radical cure: what we do not know and why it matters","volume":"15","author":"Popovici","year":"2021","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.pt.2026.02.004_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpddr.2025.100597","article-title":"Resistance to apicoplast translational inhibitors in Plasmodium","volume":"28","author":"Home","year":"2025","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.pt.2026.02.004_bb0425","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60246","article-title":"Doxycycline has distinct apicoplast-specific mechanisms of antimalarial activity","volume":"9","author":"Okada","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.pt.2026.02.004_bb0430","doi-asserted-by":"crossref","first-page":"e00416","DOI":"10.1128\/AAC.00416-19","article-title":"Kinetic driver of antibacterial drugs against Plasmodium falciparum and implications for clinical dosing","volume":"63","author":"Caton","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2026.02.004_bb0435","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/648594","article-title":"Susceptibility of Plasmodium falciparum isolates to doxycycline is associated with pftetQ sequence polymorphisms and pftetQ and pfmdt copy numbers","volume":"201","author":"Briolant","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.004_bb0440","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3201\/eid2108.150524","article-title":"Malaria prophylaxis failure with doxycycline, Central African Republic, 2014","volume":"21","author":"Madamet","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.pt.2026.02.004_bb0445","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12936-015-0980-0","article-title":"Tetracyclines in malaria","volume":"14","author":"Gaillard","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.02.004_bb0450","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1475-2875-10-S1-S4","article-title":"Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions","volume":"10","author":"Rasoanaivo","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.02.004_bb0455","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1021\/np9602325","article-title":"Antimalarial activity: the search for marine-derived natural products with selective antimalarial activity","volume":"59","author":"Wright","year":"1996","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.pt.2026.02.004_bb0460","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1039\/D5NP00013K","article-title":"Unlocking marine treasures: isolation and mining strategies of natural products from sponge-associated bacteria","volume":"42","author":"Kim","year":"2025","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.pt.2026.02.004_bb0465","series-title":"Symbiotic Microbiomes of Coral Reefs Sponges and Corals","first-page":"329","article-title":"Natural products from sponges","author":"Han","year":"2019"},{"key":"10.1016\/j.pt.2026.02.004_bb0470","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/biomedicines9050472","article-title":"Natural products that changed society","volume":"9","author":"Christensen","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.pt.2026.02.004_bb0475","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s10886-005-5795-y","article-title":"Laboratory evaluation of Artemisia annua L. extract and artemisinin activity against Epilachna paenulata and Spodoptera eridania","volume":"31","author":"Maggi","year":"2005","journal-title":"J. Chem. Ecol."},{"key":"10.1016\/j.pt.2026.02.004_bb0480","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1098\/rsif.2009.0203","article-title":"Quorum sensing and social networking in the microbial world","volume":"6","author":"Atkinson","year":"2009","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.pt.2026.02.004_bb0485","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1038\/s41396-019-0469-x","article-title":"Microbe-driven chemical ecology: past, present and future","volume":"13","author":"Schmidt","year":"2019","journal-title":"ISME J."},{"key":"10.1016\/j.pt.2026.02.004_bb0490","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4155\/fmc-2017-0294","article-title":"The polypharmacology of natural products","volume":"10","author":"Ho","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.pt.2026.02.004_bb0495","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ja.2010.71","article-title":"Biosynthesis of rapamycin and its regulation: past achievements and recent progress","volume":"63","author":"Park","year":"2010","journal-title":"J. Antibiot."},{"key":"10.1016\/j.pt.2026.02.004_bb2005","series-title":"Polypharmacology. Strategies for Multi-Target Drug Discovery","first-page":"423","article-title":"Multi-target antimalarials as a strategy to reduce resistance risk","author":"Coulson","year":"2025"},{"key":"10.1016\/j.pt.2026.02.004_bb0500","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1016\/j.tet.2003.08.082","article-title":"Kalihinols from two Acanthella cavernosa sponges: inhibitors of bacterial folate biosynthesis","volume":"60","author":"Bugni","year":"2004","journal-title":"Tetrahedron"},{"key":"10.1016\/j.pt.2026.02.004_bb0505","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1021\/ja00254a035","article-title":"Kalihinols, multifunctional diterpenoid antibiotics from marine sponges Acanthella spp","volume":"109","author":"Chang","year":"1987","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pt.2026.02.004_bb0510","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1021\/np980240g","article-title":"New diterpene isonitriles from the sponge Phakellia pulcherrima","volume":"61","author":"Wolf","year":"1998","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.pt.2026.02.004_bb0515","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/jm0010724","article-title":"Inhibition of heme detoxification processes underlies the antimalarial activity of terpene isonitrile compounds from marine sponges","volume":"44","author":"Wright","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pt.2026.02.004_bb0520","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/08927010500498623","article-title":"Antifouling properties of 10beta-formamidokalihinol-A and kalihinol A isolated from the marine sponge Acanthella cavernosa","volume":"22","author":"Yang","year":"2006","journal-title":"Biofouling"},{"key":"10.1016\/j.pt.2026.02.004_bb0525","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1021\/np50090a014","article-title":"Antimalarial activity of sesquiterpenes from the marine sponge Acanthella klethra","volume":"55","author":"Angerhofer","year":"1992","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.pt.2026.02.004_bb0530","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0305-0491(90)90274-W","article-title":"Biosynthesis of marine isocyanoterpenoids in sponges","volume":"97","author":"Chang","year":"1990","journal-title":"Comp. Biochem. Physiol. B"},{"key":"10.1016\/j.pt.2026.02.004_bb0535","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/acsmedchemlett.7b00013","article-title":"Antimalarial properties of simplified kalihinol analogues","volume":"8","author":"Daub","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.pt.2026.02.004_bb0540","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1021\/jacs.5b01152","article-title":"Synthesis and potent antimalarial activity of kalihinol B","volume":"137","author":"Daub","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pt.2026.02.004_bb0545","doi-asserted-by":"crossref","first-page":"13467","DOI":"10.1016\/S0040-4020(98)00818-7","article-title":"Antimalarial activity of kalihinol A and new relative diterpenoids from the Okinawan sponge, Acanthella sp","volume":"54","author":"Miyaoka","year":"1998","journal-title":"Tetrahedron"},{"key":"10.1016\/j.pt.2026.02.004_bb0550","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1042\/bj2950517","article-title":"Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate","volume":"295","author":"Rohmer","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.pt.2026.02.004_bb0555","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1039\/C4NP00109E","article-title":"Syntheses and biological studies of marine terpenoids derived from inorganic cyanide","volume":"32","author":"Schnermann","year":"2015","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.pt.2026.02.004_bb0560","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1039\/C0OB00326C","article-title":"Anti-malarial, anti-algal, anti-tubercular, anti-bacterial, anti-photosynthetic, and anti-fouling activity of diterpene and diterpene isonitriles from the tropical marine sponge","volume":"9","author":"Wright","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.pt.2026.02.004_bb0565","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.chembiol.2013.05.008","article-title":"Juxtaposition of chemical and mutation-induced developmental defects in zebrafish reveal a copper-chelating activity for Kalihinol F","volume":"20","author":"Sandoval","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.pt.2026.02.004_bb0570","doi-asserted-by":"crossref","DOI":"10.1126\/science.adm7966","article-title":"A kalihinol analog disrupts apicoplast function and vesicular trafficking in P. falciparum malaria","volume":"385","author":"Chahine","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.pt.2026.02.004_bb0575","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/bfgp\/elz008","article-title":"The genomic architecture of antimalarial drug resistance","volume":"18","author":"Cowell","year":"2019","journal-title":"Brief. Funct. Genomics"},{"key":"10.1016\/j.pt.2026.02.004_bb0580","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/jac\/dks504","article-title":"Antimalarial pharmacology and therapeutics of atovaquone","volume":"68","author":"Nixon","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.pt.2026.02.004_bb0585","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41392-025-02246-3","article-title":"Malaria: past, present, and future","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.pt.2026.02.004_bb0590","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4269\/ajtmh.1985.34.1022","article-title":"Cloning and characterization of mefloquine-resistant Plasmodium falciparum from Thailand","volume":"34","author":"Webster","year":"1985","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2026.02.004_bb0595","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0035-9203(94)90303-4","article-title":"Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria","volume":"88","author":"Luxemburger","year":"1994","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2026.02.004_bb0600","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.pt.2012.08.002","article-title":"PfCRT and its role in antimalarial drug resistance","volume":"28","author":"Ecker","year":"2012","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2026.02.004_bb0605","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/jep.12960","article-title":"The use of mechanistic evidence in drug approval","volume":"24","author":"Aronson","year":"2018","journal-title":"J. Eval. Clin. Pract."},{"key":"10.1016\/j.pt.2026.02.004_bb0610","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.3390\/molecules30204133","article-title":"Development of nanotechnological approaches to improving the antimalarial potential of natural substances","volume":"30","author":"Yoncheva","year":"2025","journal-title":"Molecules"}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492226000401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492226000401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T14:59:14Z","timestamp":1775055554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492226000401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":123,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1471492226000401"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2026.02.004","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polypharmacology in malaria treatment: single drugs, multiple mechanisms, greater impact","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2026.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}